chartexchange

SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights

GlobeNewswire Inc. | Nov 5, 2026 7:30 AM EST

Adult and adolescent cohorts fully enrolled in registrational SAFEGUARD study of SAB-142; Pediatric cohort (ages 5–11) actively enrolling with overall enrollment on track for completion in Q4 2026

Read original article